Advertisement

Topics

Eli Lilly Says Long-Term Use of Taltz Shows Efficacy Improvements in PsA at ACR/ARHP

19:00 EST 7 Nov 2017 | BioSpace

Interim results will be presented at an oral presentation at the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting.

Original Article: Eli Lilly Says Long-Term Use of Taltz Shows Efficacy Improvements in PsA at ACR/ARHP

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly Says Long-Term Use of Taltz Shows Efficacy Improvements in PsA at ACR/ARHP"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...